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In my contribution to this symposium I would like to 
comment on three different but interrelated aspects of 
antibiotic-resistant Streptococcus pneurnoniae. The first 
one of these has to do with the continuing ambiguity 
concerning the clinical significance of antibiotic resist- 
ance in pneumococcal Asease. The second topic will 
involve comments on day-care centers-institutions 
which emerged as novel epidemiologic units of major 
importance, intimately connected to the mechanism 
and spread of antibiotic resistance in pneumococci. 
Finally I shall briefly discuss the importance of molecular 
fingerprinting methods in studies on the epidemiology 
of resistant pneumococci. 
ANTIBIOTIC RESISTANCE AND PNEUMOCOCCAL DISEASE 
Doubts about the clinical relevance of penicillin- 
resistant s. pneurnoniae have accompanied this pathogen 
ever since the first description of penicillin-resistant 
isolates from clinical specimens. The report on one of 
the first penicillin-resistant strains recovered from a 
child in Papua New Guinea in the late 1960s prompted 
an editorial in the New England Journal of Medicine 
which recognized the potential danger of such a 
development but went on to say that the unusual nature 
of the isolate made its spread extremely unlikely [I]. 
Even after publication of the South African report in 
1977 on epidemic disease caused by multi-resistant 
pneumococci, these bacteria were often regarded as 
a microbiological curiosity related to inappropriate 
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infection control in demographic settings of poverty 
and social upheaval. It was not until the massive global 
spread of penicillin-resistant strains was documented in 
the early 1990s that the serious potential public-health 
hazard posed by these bacteria was generally recog- 
nized. 
Reluctance to recognize the danger of antibiotic- 
resistant pneumococci may have been related, at least 
in part, to the unusual microbiological properties of 
resistant strains. 
The mechanism of penicdin resistance was shown 
to involve reduced affinities for penicillin in a family of 
membrane proteins, the so-called penicillin-binding 
proteins (PBPs) (cell wall synthetic enzymes essential 
for bacterial survival), a potentially ‘risky’ maneuver for 
the bacteria, since such a mechanism might also affect 
the catalytic activity of these proteins in their normal 
physiologic functions [Z]. Indeed, mutants generated in 
the laboratory and carrying simdar mechanisms of 
drug resistance were known to grow slowly and have 
abnormal morphology. Another peculiar property 
identified in several highly resistant clinical isolates was 
the drastically altered chemical composition of their 
cell walls, which was unlike the cell wall composition 
characteristic of this bacterial species [3] .  In addition, 
the overwhelming majority of resistant strains belonged 
to only a limited number-four to five-(of the total 
of 90) of pneumococcal serotypes, those corresponding 
to serotypes carried by children of pre-school age [4]. 
Ail these peculiarities, and particularly the narrow 
serotype hstribution of resistant pneumococci, raised 
questions about their potential impact on invasive 
disease. The most frequent serotypes of invasive 
pneumococci differ from those characteristic of drug- 
resistant strains and, in initial surveys, antibiotic resist- 
ance was shown to be relatively rare among invasive 
isolates. For instance, in a survey performed in the early 
1990s in Portugal, drug-resistant pneumococci repre- 
sented only a few per cent of invasive isolates, while the 
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frequency of resistant strains among all clinical isolates 
approached 25% [5]. 
While the danger of treatment failure caused by 
even moderately penicillin-resistant strains has become 
well recognized in meningitis, the therapeutic impor- 
tance of penicillin-resistant strains in systemic disease 
remains less clear. It was demonstrated that raising 
therapeutic doses of penicillin could cure pneumo- 
coccal pneumonia caused by strains with penicillin MIC 
values up to 1-2 mg/mL [6],  which is the resistance 
level most common among current epidemic strains of 
pneumococci. 
These notions raised questions about the stability 
and virulence of resistant strains and also about the 
clinical importance of antibiotic-resistant pneumococci 
in general. It  may be worthwhile examining the validity 
of these notions in some detail. 
The biological price of antibiotic resistance 
Mechanisms of drug resistance that involve alterations 
of target molecules may also impair their physiologically 
important functions, i.e. may extract a kind of ‘bio- 
logical price’ from the bacteria, leading to suboptimal 
growth of resistant strains and to instability in the 
competitive in vivo environment. That the core idea of 
‘biological price’ may be correct is suggested by the 
physiologic abnormalities of penicillin-resistant labora- 
tory mutants of pneuniococci which have been isolated 
since the 1950s, even before the first clinical isolate was 
described. The basic mechanism of penicillin resistance 
in the laboratory mutants is similar to that identified in 
resistant clinical isolates, i.e. reduction in the antibiotic 
affinities of the four high molecular weight PBPs, and 
slow growth rate in laboratory media, abnormal cell 
morphology and premature autolysis are common 
features of penicillin-resistant laboratory mutants. In 
contrast, morphologic and physiologic defects are absent 
from resistant clinical isolates, in spite of the similarity 
of underlying resistance mechanisms [7]. 
Several multi-resistant South A6-ican and Hungarian 
S. pneumoniae clinical strains grew with normal rates, 
retained normal cellular morphology, and showed no 
detectable change in antibiotype or resistance level 
during extensive passage for up to several thousand cell 
generations in the absence of antibiotic selection in the 
laboratory. The same strains inoculated into mice 
(which were then treated with penicillin to achieve a 
‘clinical’ cure of disease) could also be recovered from 
the spleen of the animals in a form indicating the 
complete stability of the multi-resistance pattern [8]. 
Abnormal cell wall composition and penicillin resistance 
Abnormality of muropeptide composition was first 
documented in the peptidoglycan of several penicillin- 
resistant clinical isolates and was subsequently also 
demonstrated in highly penicillin-resistant laboratory 
mutants. In the species-specific muropeptide com- 
position of pneumococcal cell walls, the ratio of cross- 
linked to monomeric components is always about 2/3 
to 1/3 of the muropeptide units, and this ratio is 
carefully preserved among clinical isolates of penicillin- 
susceptible and penicillin-resistant strains, in spite of the 
fact that the latter often contain muropeptide subunits 
of anomalous chemical structure [9]. In sharp contrast, 
the laboratory isolates of penicillin-resistant pneumo- 
cocci produced a peptidoglycan, the muropeptide 
composition of which showed that it was the product 
of a set of catalytically inefficient transpeptidases pro- 
ducing a poorly cross-linked, unstable cell wall in 
which the ratio of monomeric to cross-linked units was 
reversed [7]. It was suggested that a critical difference 
between laboratory and clinical isolates may be the 
presence of hypothetical ‘fitness’ genes in the latter, 
which may allow resistant cells emerging in the clinical 
environment to utilize altered muropeptide precursors 
for the synthesis of bacterial cell walls. Such altered 
precursors may have a better ‘fit’ into the remodeled 
active sites of penicillin-resistant PBPs [2]. The source 
of such fitness genes may be available for bacteria in the 
in vivo environment, presumably from heterologous 
sources through mechanisms of recombination. 
Penicillin resistance of S. pneumoniae: restriction to 
unique serotypes 
The dominance of pediatric capsular types among 
antibiotic-resistant pneumococci is well established. 
While the reasons for this are not clear, the association 
of resistance with these particular serotypes can explain 
the high frequency of resistant pneumococci among 
strains colonizing young children, particularly those 
attending day care. The unique pediatric serotypes 
may also explain the frequency of antibiotic-resistant 
pneumococci among strains from upper respiratory 
infections of children. 
However, the relative rarity of resistant strains 
among invasive isolates may no longer exist. In a recent 
surveillance study on pneumococci causing invasive 
disease in children, performed in six Latin American 
countries, strains belonging to two internationally 
spread antibiotic-resistant clones of pneumococci 
were recovered from all sterile sites with the same 
frequency as average penicillin-susceptible pneumo- 
cocci, in spite of the fact that the resistant bacteria 
belonged to serotypes 9, 14 or 23F [lo]. The frequent 
occurrence of the same two clones as causative agents 
of adult pneumonia was also demonstrated in a 
multicenter study performed in the USA in 1996 and 
1997 [ l l ] .  
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The success of penicillin therapy of pneumonia 
caused by penicillin-resistant strains with MICs up to 
2 mg/L indicates that therapy of infections by such 
strains (which include several of the extensively spread 
multiresistant clones of S. pneumoniae) may not require 
new antibacterial agents. However, for how long this 
may remain the case is not clear. Isolates with extremely 
high penicillin MIC values (8-16 mg/L) do exist now 
among epidemic strains, which include the two major 
internationally dispersed pneumococcal clones, and 
one cannot set an upper limit to penicillin MIC values 
on mechanistic grounds. It would also serve as a note 
of warning that high-level levofloxacin resistance has 
already been detected among some US isolates belong- 
ing to the internationally spread Spanish/USA clone 
The most compelling evidence against the notion 
of a ‘handicap’ associated with antibiotic resistance is 
the superb epidemicity of several multiresistant S. 
pneumoniae clones. The multiresistant clone, often 
referred to as the ‘Spanish/USA 23F’ S. pneumoniae, 
carrying resistance traits to penicillin, tetracycline, 
chloramphenicol, and frequently macrolides and sulfa- 
methoxazole-trimethoprim as well, has become a 
pandemic clone spread in many countries on five 
continents [12]. Extensive geographic spread was also 
documented for a t  least two additional epidemic 
clones: the multiresistant serotype 6B ‘Icelandic’ S. 
pneumoniae [13] and the penicillin- and sulfameth- 
oxazole-trimethoprim-resistant ‘French/Spanish’ clone, 
usually expressing serotypes 9 or 14 [14]. 
[111. 
DAY-CARE CENTERS: RISK AND OPPORTUNITY 
The virtual restriction of antibiotic-resistant pneumo- 
cocci to pediatric capsular types strongly suggests that 
the major global reservoir of these strains may be the 
microbial flora colonizing young children, particularly 
children of pre-school age. Due to social trends in the 
developed world, an increasing proportion of children 
of this age group are being cohorted into day-care 
centers. The close proximity of a large number of 
children together with the frequency of viral respiratory 
infections, the immaturity of the immune system, and 
behavioral traits, make day-care centers a high-risk 
environment for the dispersal of any infectious agent, 
including respiratory pathogens such as S. pneumoniae, 
Haemophilus injuenzae, and Moraxella catarrhalis, which 
frequently colonize the nasopharynx of children. 
Another aspect of the day-care centers is also of 
importance. Pneumococcal otitis media, a frequent 
disease affecting children of day-care age and the single 
most frequent cause of visits to doctors’ offices, is linked 
to the prescription of enormous quantities of anti- 
bacterial agents. There is little doubt that the powerful 
selective pressure generated by the extensive use of 
antibacterial agents is in major part responsible for the 
unusually high frequency of antibiotic-resistant strains 
among members of the pneumococcal flora colonizing 
the nasopharynx of children attending day-care centers. 
The inability of the immune system of this age 
group to mount an antibody response to pneumo- 
cocci expressing the ‘pediatric’ serotypes, which most 
frequently carry drug resistance traits, the conditions 
favoring frequency of transmission, and the frequent 
use of antibiotics, make day-care centers places of high 
risk. For the same reasons, day-care centers also offer 
unique opportunities for testing interventions that are 
aimed at reducing the frequency of carriage of anti- 
biotic-resistant strains in children. 
Day-care centers as autonomous epidemiologic units 
The capacity of extensive antibiotic use to select for 
resistant strains is a well-established fact, and data exist 
in the literature that indicate a crude semiquantitative 
relationship between the amounts of drugs used and the 
prevalence of antibiotic-resistant strains in various 
countries. Nevertheless, beyond the general truism of 
this relationship, specific and quantitative information 
as to the amounts of antibiotic used and the prevalence 
of antibiotic-resistant bacteria is not well understood 
and the importance of such a relationship for com- 
munity-acquired disease has only become recognized 
recently. The aim of international efforts described in 
the contributions that appear in this special issue of 
CMI is to introduce designs for intervention strategies 
which would impact on the prevalence of pneumo- 
coccal disease through implementing measures that can 
lower the prevalence of resistant pneumococci in their 
major ecological reservoir, which is the colonizing flora 
of children. In order to make such studies quantitative, 
and in order to maximize their potential impact, it was 
recognized that surveillance of the colonizing flora of 
children in day-care centers may provide a system in 
which the success or failure of intervention methods 
may be evaluated. 
Studies performed in day-care centers in Lisbon 
between 1996 and 1998 suggest that a day-care center 
may indeed provide such an ‘autonomous’ epidemio- 
logic unit. The definition of such a unit is primarily 
based on the frequency of transmission of a unique 
microbial flora among attendees of a day-care center. 
Studies on the S. pneumoniae isolates recovered at 
Lisbon day-care centers and characterized by molecular 
fingerprinting techniques suggest that most, if not all, 
of these day-care centers have a characteristic and 
unique pneumococcal flora. This finding suggests that 
introduction of appropriate intervention measures, e.g. 
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reduced use of antibacterial agents or methods that 
decrease child-to-child transmission, may effectively 
improve the situation in a single day-care center with- 
out necessarily having to impact on all the other day- 
care centers as well. 
MOLECULAR TECHNIQUES IN EPIDEMIOLOGIC 
PROBLEM-SOLVING 
Day-care centers provide clear spatial and temporal 
confines for epidemiologic studies on factors that 
determine the host-to-host movement of community- 
acquired bacterial pathogens such as S. pneumoniae, for 
which the nasopharynx of children is a ‘sanctuary’. In 
this last section I shall describe such epidemiologic 
studies, with special reference to the use of molecular 
fingerprinting tools which are currently being intro- 
duced into such investigations. 
Besides leading to problems of treatment failure, 
multiresistant strains of pneumococci also make 
epidemiologic tracking difficult, since one of the most 
useful traditional tracking methods involved the use of 
antibiotyper. Multiresistant strains clearly distinguish- 
able from one another by molecular probes but 
carrying virtually identical antibiotic resistance traits 
have now been described among both nosocomial and 
community-acquired pathogens. Furthermore, while 
serotyping will clearly remain an important tool of 
characterization, pneumococci sharing a common 
serotype are often genetically heterogeneous, thus 
excluding similarity of serotype as a tool for identif$ng 
pneumococcal strains. The importance of using mole- 
cular typing tools for solving standard epidemiologic 
questions can be demonstrated on all levels, beginning 
with individual patients, through larger epidemiologic 
units such as day-care centers or hospitals, all the way 
up to involving several hospitals in a town or even an 
entire country. In what follows, I shall provide simple 
illustrations for such cases, taking examples mostly from 
the Lisbon Day Care Center Initiative 1151, which has 
been routinely using molecular fingerprinting methods 
for the characterization of S. pneirrnoniae colonizing the 
nasopharynx of children. 
HeterogeneiG of capsular serotypes 
During the first year (1996) of the Lisbon Day Care 
Center Study, the majority ofisolates (22 of 35, or over 
60%) with an intermediate level of penicillin resistance 
belonged to serogroup 19, and such strains were 
identified in four of the seven participating day-care 
centers, suggesting extensive center-to-center spread of 
this bacterium [15]. Yet this conclusion would be 
grossly inaccurate, since molecular fingerprinting of the 
strains involved showed that the serogroup 19 isolates 
were actually a heterogeneous group represented by 
five distinct PFGE types and five different antibiotypes, 
and the combination of these two properties could 
define eight distinct ‘strains’, only two of which were 
present in the same day-care center: each of the rest of 
the six strains was confined to a single day-care center 
only. 
Appearance of a new pneumococcal serotype 
Shifts in the prevalence of pneumococcal serotypes, 
among both colonizing and invasive strains, have been 
repeatedly described in the literature. Such shifts can 
even be observed during a longitudinal analysis of the 
nasopharyngeal flora of single children. It has usually 
been assumed that such a change in capsular type 
involves appearance of a new pneumococcal strain. 
However, use of molecular typing tools has demon- 
strated that such a change in capsular type may involve 
an alternative mechanism as well, namely, the spon- 
taneous acquisition and exchange of capsular genes 
without loss of the colonizing bacterium, as defined by 
molecular typing techniques. An accurate estimate of 
the frequency of such spontaneous capsular switch 
events is not possible. However, the frequency of 
occurrence of S. pneurnoniae strains belonging to a 
common genetic lineage but expressing ‘anomalous’ 
capsular types can be estimated from molecular 
epidemiologic surveys. For instance, of the 127 peni- 
cillin-resistant pneumococcal isolates from the USA 
with the genotype of the Spanish/USA clone, which 
most frequently expresses the 23F capsule, as many as 
34 expressed capsular type 19; three isolates had 
capsular type 14; and one was non-typable 1111. It was 
pointed out that such capsular shifts may lead to a 
temporary advantage for a colonizing strain over the 
immune system. In addition, capsular switch could 
maneuver an entire multiresistance pattern into a new 
serotype by a single genetic event. In at least one 
recently described spontaneous capsular switch event, 
not only did the resistant bacteria acquire a new 
serotype (serotype 3 ) ,  unusual for multiresistant strains, 
but the isolates with the changed capsule also showed 
dramatic increase in virulence as tested by the mouse 
intraperitoneal model [ 161. 
Increase in the frequency of carriage of resistant 
pneumococci 
An increase of 26-34% was observed in the Lisbon Day 
Care Center studies between 1996 and 1997, and this 
was paralleled by the increase in serogroup 23 isolates; 
the increase was primarily among isolates with inter- 
mediate levels of resistance [17]. Interpretation of these 
changes on the basis of serotype and antibiotic resistance 
pattern alone would suggest that there was proliferation 
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of the intermediate level 23F strain that was present 
already in the 1996 survey. In fact, molecular typing of 
the 1997 isolates showed the appearance of a com- 
pletely new set of clonal types with the same serogroup 
and resistance level. 
Resistance developing during treatment 
A frequently posed question is the origin of increased 
antibiotic resistance in patients undergoing chemo- 
therapy. Is it that the MIC of the original strain is 
increased due to antibiotic pressure? O r  did antibiotic 
pressure allow cross-infection with a new strain? A safe 
distinction between these two radically different 
alternatives again requires application of molecular 
tools. Evidence for the first type of mechanism has 
recently been described in the case of methicillin- 
resistant Staphylococcus aureus with decreased suscepti- 
bility to vancomycin [18]. A similar mechanism must 
be responsible for the appearance of clinical isolates 
with identical PFGE patterns but widely different 
MIC values, which cover the entire range from fully 
susceptible up to hghly resistant isolates with penicillin 
MIC values of 8-16 mg/L, as was recently described 
among some isolates from the USA [ l l ] .  Cases of the 
second type of scenario have also been described in the 
case of individual patients. An abrupt rise in the 
prevalence of high-level penicillin resistance is often 
due to the ‘import’ and spread of new highly resistant 
strains from abroad. 
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